Oct 20 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a head-to-head . AbbVie has been ...
NORTH CHICAGO, Ill., Oct. 20, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
Stacker on MSNOpinion
Comparing 12 common rheumatoid arthritis prescriptions
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
The last time I wrote about AbbVie (ABBV) was with respect to a Seeking Alpha article entitled "AbbVie: Skyrizi And Rinvoq Latest FDA Approvals Bode Well For Humira Patent Loss". With this respect to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback